▁Introduction 7.8203125
: 1.9072265625
<0x0A> 6.51953125
P 5.1015625
rem 5.19140625
ature 2.283203125
▁men 5.23046875
op 0.0361328125
ause 0.0048828125
▁in 3.9375
▁middle 6.078125
- 0.402099609375
aged 0.051544189453125
▁women 0.218017578125
▁with 4.48046875
▁ob 5.3203125
es 0.16015625
ity 0.0003063678741455078
▁and 2.154296875
▁a 3.818359375
▁pre 5.30078125
dis 0.7841796875
position 0.0557861328125
▁to 0.27001953125
▁breast 3.55078125
▁cancer 0.049713134765625
▁is 1.033203125
▁a 1.1328125
▁complex 3.720703125
▁condition 3.029296875
▁that 1.5849609375
▁requires 1.7314453125
▁careful 2.4453125
▁consideration 2.4609375
▁in 3.078125
▁treatment 3.623046875
▁options 3.580078125
. 0.2587890625
▁This 2.6953125
▁ess 6.640625
ay 0.0011110305786132812
▁a 3.7109375
ims 0.0036678314208984375
▁to 0.0260772705078125
▁analyze 4.09765625
▁the 0.568359375
▁potential 4.5625
▁ris 2.78515625
ks 0.00013756752014160156
▁and 0.65185546875
▁benefits 0.1370849609375
▁of 0.1708984375
▁using 3.0
▁Met 6.69921875
op 6.515625
rol 0.0249481201171875
ol 0.00046706199645996094
▁and 2.2265625
▁Nor 7.90625
vas 1.9833984375
c 0.0031490325927734375
▁in 1.130859375
▁man 4.421875
aging 0.0008287429809570312
▁these 3.72265625
▁sympt 2.0390625
oms 0.00162506103515625
▁while 3.416015625
▁highlight 4.63671875
ing 0.0013751983642578125
▁the 0.63525390625
▁cru 5.34375
cial 0.0003459453582763672
▁role 0.40283203125
▁of 0.325927734375
▁di 2.958984375
et 0.01381683349609375
▁and 0.3515625
▁sm 9.84375
oking 0.0014028549194335938
▁c 0.13720703125
ess 0.0005340576171875
ation 0.00015485286712646484
▁in 0.258056640625
▁optim 3.87109375
izing 0.0162200927734375
▁treatment 1.60546875
▁out 0.097412109375
comes 5.0187110900878906e-05
. 0.0308685302734375
<0x0A> 0.264404296875
Body 6.04296875
: 0.490966796875
<0x0A> 1.2802734375
Met 1.0615234375
op 0.019195556640625
rol 0.0001354217529296875
ol 3.528594970703125e-05
▁and 0.25927734375
▁Nor 0.005916595458984375
vas 0.0010652542114257812
c 0.000118255615234375
▁E 10.4140625
ffic 0.447021484375
acy 0.03802490234375
: 0.5302734375
<0x0A> 0.169921875
Met 0.3857421875
op 0.0053558349609375
rol 0.0001024007797241211
ol 2.562999725341797e-05
▁and 0.176513671875
▁Nor 0.00887298583984375
vas 0.00039887428283691406
c 0.0001538991928100586
, 3.19140625
▁both 1.4736328125
▁commonly 4.046875
▁pres 0.88330078125
cribed 0.00048351287841796875
▁medic 1.30859375
ations 0.0219879150390625
, 1.724609375
▁operate 9.734375
▁through 3.162109375
▁different 0.564453125
▁mechan 0.0816650390625
isms 0.00016236305236816406
▁to 0.88623046875
▁manage 1.8388671875
▁men 3.146484375
op 0.0036411285400390625
aus 0.61865234375
al 0.0011167526245117188
▁sympt 0.0196990966796875
oms 0.0014820098876953125
. 0.86279296875
▁Met 0.356201171875
op 0.0011453628540039062
rol 9.441375732421875e-05
ol 1.4543533325195312e-05
▁belongs 3.72265625
▁to 0.0013675689697265625
▁the 0.261474609375
▁beta 0.302490234375
- 0.11578369140625
block 0.0341796875
er 0.020721435546875
▁class 0.368896484375
▁and 2.173828125
▁primarily 4.73828125
▁controls 5.41015625
▁blood 1.349609375
▁pressure 0.0295867919921875
▁and 2.365234375
▁heart 0.1546630859375
▁rate 0.06866455078125
, 1.1708984375
▁while 0.301513671875
▁Nor 0.00949859619140625
vas 0.0004107952117919922
c 7.18832015991211e-05
, 3.5703125
▁a 0.310546875
▁calci 0.05438232421875
um 1.8715858459472656e-05
▁channel 0.065185546875
▁block 0.00814056396484375
er 0.0010385513305664062
, 0.0138702392578125
▁rela 3.8671875
xes 6.031990051269531e-05
▁blood 1.2861328125
▁vessels 0.037017822265625
▁to 2.0703125
▁reduce 1.8798828125
▁hy 2.22265625
pert 0.0002493858337402344
ension 0.00319671630859375
. 0.6328125
<0x0A> 1.51953125
Met 2.814453125
op 0.01947021484375
rol 0.0001844167709350586
ol 7.665157318115234e-05
' 3.994140625
s 0.0004982948303222656
▁Pot 3.63671875
ential 0.011505126953125
▁Ris 0.599609375
ks 7.700920104980469e-05
▁and 1.8466796875
▁Ben 0.07305908203125
ef 1.6689300537109375e-06
its 0.0008997917175292969
: 0.1192626953125
<0x0A> 0.0574951171875
Met 0.9462890625
op 0.0030078887939453125
rol 0.0002627372741699219
ol 4.0531158447265625e-06
' 1.4677734375
s 0.0001442432403564453
▁use 2.71484375
▁car 4.83203125
ries 0.00043702125549316406
▁potential 1.3017578125
▁ris 0.2484130859375
ks 4.291534423828125e-06
▁and 2.736328125
▁benefits 0.1351318359375
▁specific 6.42578125
▁to 0.0029354095458984375
▁middle 2.658203125
- 0.002819061279296875
aged 0.004364013671875
▁women 0.160400390625
▁with 0.1546630859375
▁ob 0.1519775390625
es 0.0014190673828125
ity 4.589557647705078e-05
▁and 0.107421875
▁a 0.316162109375
▁pre 0.1163330078125
dis 0.0003190040588378906
position 0.0005559921264648438
▁to 0.07666015625
▁breast 0.0076141357421875
▁cancer 0.0004622936248779297
. 0.06048583984375
▁A 4.4375
▁potential 3.078125
▁benefit 1.3720703125
▁of 0.340576171875
▁using 2.193359375
▁Met 0.2303466796875
op 0.0008397102355957031
rol 0.0024394989013671875
ol 1.1563301086425781e-05
▁is 0.2880859375
▁its 0.450927734375
▁impact 5.328125
▁on 0.0182952880859375
▁card 3.201171875
i 0.0267791748046875
ov 0.004428863525390625
asc 2.3245811462402344e-05
ular 0.00012159347534179688
▁health 0.64990234375
, 0.65478515625
▁which 1.3388671875
▁may 1.53515625
▁be 1.5107421875
▁especially 2.91015625
▁critical 3.0546875
▁for 0.36328125
▁ob 3.03515625
ese 0.0030994415283203125
▁patients 2.19921875
▁at 2.353515625
▁a 2.875
▁higher 0.216552734375
▁risk 0.0020961761474609375
▁of 0.278564453125
▁heart 0.6005859375
▁disease 0.1298828125
. 0.1365966796875
▁Additionally 2.173828125
, 0.00024080276489257812
▁Met 0.390869140625
op 0.0004763603210449219
rol 0.00018155574798583984
ol 1.9550323486328125e-05
▁may 0.951171875
▁help 1.3056640625
▁alle 2.443359375
vi 5.364418029785156e-06
ate 3.361701965332031e-05
▁sympt 2.484375
oms 0.00113677978515625
▁like 2.90625
▁hot 0.1229248046875
▁flash 0.0310516357421875
es 0.00013959407806396484
▁and 0.438720703125
▁sleep 3.27734375
▁dist 0.460205078125
urban 0.0003070831298828125
ces 4.076957702636719e-05
▁associated 2.025390625
▁with 0.0001659393310546875
▁men 0.13720703125
op 0.00013375282287597656
ause 0.0168609619140625
. 0.26416015625
▁However 1.3876953125
, 0.00023257732391357422
▁studies 5.07421875
▁suggest 1.5791015625
▁that 0.191162109375
▁Met 0.6259765625
op 0.0005002021789550781
rol 0.000514984130859375
ol 4.410743713378906e-06
▁might 4.921875
▁increase 0.8056640625
▁the 0.342529296875
▁risk 0.03302001953125
▁of 0.005123138427734375
▁di 2.896484375
ab 0.01186370849609375
etes 0.0016021728515625
▁and 0.859375
▁met 6.3359375
abol 0.035308837890625
ic 0.0031261444091796875
▁synd 0.4296875
rome 0.01177978515625
, 1.0986328125
▁which 1.830078125
▁can 1.333984375
▁comp 3.228515625
ound 1.224609375
▁the 0.615234375
▁challeng 3.486328125
es 0.0017719268798828125
▁faced 1.1484375
▁by 0.00572967529296875
▁ob 0.50830078125
ese 0.0039215087890625
▁patients 0.6015625
. 0.8017578125
<0x0A> 0.383056640625
N 0.11212158203125
or 0.0010862350463867188
vas 0.00024080276489257812
c 0.00013566017150878906
' 0.12384033203125
s 0.000274658203125
▁Pot 0.1107177734375
ential 0.00030922889709472656
▁Ris 0.0048980712890625
ks 1.3113021850585938e-06
▁and 0.00302886962890625
▁Ben 0.00034236907958984375
ef 8.344650268554688e-07
its 6.306171417236328e-05
: 0.00835418701171875
<0x0A> 0.00047469139099121094
On 4.18359375
▁the 0.0019817352294921875
▁other 0.006622314453125
▁hand 0.00041031837463378906
, 0.00013577938079833984
▁Nor 0.042327880859375
vas 0.00037598609924316406
c 3.075599670410156e-05
▁presents 4.87109375
▁its 1.353515625
▁own 0.171875
▁potential 2.0234375
▁ris 0.11322021484375
ks 1.1920928955078125e-07
▁and 0.0039825439453125
▁benefits 0.00078582763671875
. 0.375
▁The 2.908203125
▁benefits 3.2265625
▁of 0.1673583984375
▁Nor 0.6259765625
vas 0.00014770030975341797
c 9.679794311523438e-05
▁include 0.391357421875
▁its 0.61328125
▁ability 0.900390625
▁to 0.00013244152069091797
▁reduce 1.150390625
▁hy 1.3349609375
pert 1.609325408935547e-05
ension 0.0007243156433105469
▁and 0.71044921875
▁improve 0.77587890625
▁blood 1.0029296875
▁flow 0.270263671875
, 0.318603515625
▁which 0.46435546875
▁may 0.73681640625
▁help 1.55078125
▁manage 2.80078125
▁men 0.77734375
op 0.001583099365234375
aus 0.301513671875
al 0.00018537044525146484
▁sympt 0.006778717041015625
oms 0.0006470680236816406
▁such 2.5625
▁as 0.0001348257064819336
▁vas 4.28125
om 0.044677734375
ot 0.0011262893676757812
or 0.00019311904907226562
▁sympt 0.1357421875
oms 0.0009555816650390625
▁and 0.71142578125
▁potentially 6.671875
▁reduce 0.42724609375
▁the 0.114990234375
▁risk 0.0150146484375
▁of 0.002216339111328125
▁card 1.103515625
i 0.0086517333984375
ov 0.00046706199645996094
asc 7.987022399902344e-06
ular 3.933906555175781e-06
▁events 1.5927734375
. 0.267578125
▁However 0.37255859375
, 0.0001437664031982422
▁Nor 0.634765625
vas 4.112720489501953e-05
c 5.626678466796875e-05
▁has 2.646484375
▁been 0.26806640625
▁linked 1.7529296875
▁to 0.056365966796875
▁peri 5.59375
pher 0.0018491744995117188
al 0.00020396709442138672
▁ed 0.671875
ema 0.002197265625
, 0.8193359375
▁which 0.97412109375
▁could 2.7734375
▁be 1.1103515625
▁problem 1.7578125
atic 3.314018249511719e-05
▁for 0.08203125
▁patients 2.0390625
▁with 0.20556640625
▁ob 0.433837890625
es 0.002887725830078125
ity 5.841255187988281e-06
. 1.3330078125
▁Furthermore 2.587890625
, 0.00010263919830322266
▁its 3.740234375
▁potential 2.3828125
▁impact 2.0546875
▁on 0.01204681396484375
▁breast 3.275390625
▁cancer 0.07000732421875
▁risk 0.380126953125
▁war 2.296875
r 0.00010120868682861328
ants 8.344650268554688e-06
▁careful 1.44921875
▁consideration 0.128662109375
, 1.6640625
▁particularly 1.58984375
▁in 1.1015625
▁women 2.072265625
▁already 4.09375
▁pre 2.21484375
dis 0.0007710456848144531
posed 0.00031566619873046875
▁to 0.0828857421875
▁the 0.20947265625
▁disease 0.16455078125
. 0.01025390625
<0x0A> 0.01468658447265625
D 0.8779296875
iet 0.0027065277099609375
▁and 0.124755859375
▁Sm 0.149169921875
oking 0.0005316734313964844
▁Consider 6.8984375
ations 0.01233673095703125
▁in 2.984375
▁Tre 0.82763671875
at 0.11297607421875
ment 0.0020599365234375
: 0.38134765625
<0x0A> 0.0012140274047851562
Management 9.1328125
▁of 0.06390380859375
▁prem 3.00390625
ature 7.343292236328125e-05
▁men 0.006595611572265625
op 3.0517578125e-05
ause 0.0014667510986328125
▁in 0.2078857421875
▁middle 0.1268310546875
- 0.0012359619140625
aged 0.0006189346313476562
▁women 0.04656982421875
▁with 0.033447265625
▁ob 0.006832122802734375
es 9.202957153320312e-05
ity 1.728534698486328e-05
▁and 0.056121826171875
▁a 0.043487548828125
▁pre 0.01531219482421875
dis 3.409385681152344e-05
position 0.0002601146697998047
▁to 0.00537872314453125
▁breast 0.0009298324584960938
▁cancer 0.0001481771469116211
▁should 3.76953125
▁account 3.958984375
▁for 0.0031032562255859375
▁the 1.6650390625
▁significant 4.2421875
▁roles 4.640625
▁of 0.625
▁di 0.06622314453125
et 0.00011539459228515625
▁and 0.00920867919921875
▁sm 0.01215362548828125
oking 1.0609626770019531e-05
▁hab 4.7421875
its 3.421306610107422e-05
. 0.66162109375
▁A 1.45703125
▁well 2.74609375
- 0.0003132820129394531
des 4.38671875
igned 0.0008168220520019531
, 2.466796875
▁bal 1.1953125
anced 1.7881393432617188e-05
▁di 0.1082763671875
et 0.00010025501251220703
▁that 1.59765625
▁prom 3.197265625
otes 0.0004093647003173828
▁weight 0.89453125
▁loss 0.08001708984375
, 2.1171875
▁such 5.3515625
▁as 0.00042939186096191406
▁the 0.29638671875
▁Mediter 0.281982421875
rane 8.249282836914062e-05
an 0.00017273426055908203
▁di 0.1837158203125
et 5.412101745605469e-05
, 0.08453369140625
▁can 0.873046875
▁help 0.84716796875
▁address 4.00390625
▁the 1.724609375
▁ob 1.3515625
es 0.002323150634765625
ity 3.337860107421875e-05
▁component 1.9453125
▁while 2.466796875
▁impro 3.291015625
ving 2.1457672119140625e-05
▁overall 0.70068359375
▁health 0.16064453125
▁and 1.26171875
▁reducing 0.53076171875
▁the 0.281494140625
▁risk 0.04364013671875
▁of 0.00852203369140625
▁card 0.87060546875
i 0.0015172958374023438
ov 0.004726409912109375
asc 1.1682510375976562e-05
ular 0.00033736228942871094
▁comp 4.13671875
lications 0.0004832744598388672
. 0.1015625
▁Sm 1.8203125
oking 0.007518768310546875
▁c 0.031982421875
ess 5.3763389587402344e-05
ation 3.337860107421875e-06
▁is 0.3876953125
▁cru 2.15625
cial 0.0001678466796875
, 1.7998046875
▁as 0.1734619140625
▁sm 1.2939453125
oking 0.007534027099609375
▁has 1.869140625
▁been 0.0469970703125
▁consist 6.33203125
ently 2.193450927734375e-05
▁associated 1.4541015625
▁with 0.0004489421844482422
▁increased 1.62890625
▁ris 2.92578125
ks 1.6927719116210938e-05
▁of 0.10076904296875
▁both 3.162109375
▁breast 1.01953125
▁cancer 0.1260986328125
▁and 0.00572967529296875
▁card 0.487548828125
i 0.0028514862060546875
ov 0.0005125999450683594
asc 1.0848045349121094e-05
ular 9.5367431640625e-06
▁dise 1.8818359375
ases 2.8133392333984375e-05
. 0.169677734375
▁Im 5.7734375
plement 0.150146484375
ing 0.0003311634063720703
▁appropriate 5.45703125
▁di 1.4755859375
et 0.0012149810791015625
ary 0.6591796875
▁and 0.2548828125
▁sm 0.4658203125
oking 3.1828880310058594e-05
▁c 0.82568359375
ess 4.6133995056152344e-05
ation 0.00024700164794921875
▁inter 2.208984375
vent 0.0027027130126953125
ions 3.2186508178710938e-06
▁will 4.390625
▁maxim 4.0546875
ize 0.0016193389892578125
▁treatment 1.732421875
▁out 0.3310546875
comes 1.0728836059570312e-05
. 1.8408203125
<0x0A> 0.03302001953125
Con 1.189453125
clusion 0.040802001953125
: 0.0557861328125
<0x0A> 2.09375
In 0.50146484375
▁conclusion 0.22021484375
, 0.00029730796813964844
▁the 2.353515625
▁potential 3.599609375
▁ris 0.482177734375
ks 3.5762786865234375e-07
▁and 0.01522064208984375
▁benefits 0.0006794929504394531
▁of 0.04730224609375
▁using 1.1708984375
▁Met 0.0173187255859375
op 0.0006389617919921875
rol 0.0002071857452392578
ol 5.364418029785156e-06
▁or 3.978515625
▁Nor 0.0017175674438476562
vas 3.6597251892089844e-05
c 2.2530555725097656e-05
▁for 2.439453125
▁tre 2.703125
ating 1.9073486328125e-05
▁sympt 2.994140625
oms 0.01373291015625
▁of 0.31787109375
▁prem 0.06646728515625
ature 6.699562072753906e-05
▁men 0.002719879150390625
op 2.6345252990722656e-05
ause 0.0002620220184326172
▁in 0.0694580078125
▁middle 0.059234619140625
- 0.0010766983032226562
aged 0.0006213188171386719
▁women 0.0095367431640625
▁with 0.0079498291015625
▁ob 0.00910186767578125
es 5.5789947509765625e-05
ity 1.537799835205078e-05
▁and 0.014984130859375
▁a 0.038665771484375
▁pre 0.0184478759765625
dis 4.374980926513672e-05
position 0.0003070831298828125
▁to 0.0098876953125
▁breast 0.0004992485046386719
▁cancer 0.0001958608627319336
▁are 3.20703125
▁complex 0.798828125
. 0.81396484375
▁A 2.576171875
▁compreh 1.7744140625
ensive 0.0001169443130493164
▁understanding 4.6640625
▁of 0.0148773193359375
▁the 0.86376953125
▁unique 4.02734375
▁characteristics 3.158203125
▁and 1.9736328125
▁potential 3.306640625
▁ad 4.02734375
verse 2.1457672119140625e-05
▁effects 0.14013671875
▁of 0.234375
▁each 1.0751953125
▁medic 0.295166015625
ation 0.00023758411407470703
▁is 0.4423828125
▁essential 0.84619140625
. 2.4296875
▁Furthermore 3.005859375
, 8.082389831542969e-05
▁the 2.365234375
▁integration 4.96875
▁of 0.0017938613891601562
▁a 2.822265625
▁well 0.7666015625
- 0.0005669593811035156
bal 2.931640625
anced 8.893013000488281e-05
▁di 0.0570068359375
et 6.99758529663086e-05
▁and 0.229248046875
▁sm 0.059967041015625
oking 8.976459503173828e-05
▁c 0.00240325927734375
ess 2.8967857360839844e-05
ation 3.063678741455078e-05
▁inter 1.5908203125
vent 0.0096282958984375
ions 1.5497207641601562e-06
▁plays 4.1796875
▁a 0.078125
▁critical 1.55078125
▁role 0.0020046234130859375
▁in 0.0064239501953125
▁optim 0.74755859375
izing 0.0006694793701171875
▁the 3.2890625
▁overall 3.23828125
▁treatment 0.5859375
▁plan 2.615234375
. 0.5029296875
▁A 4.51953125
▁mult 1.3896484375
id 0.0648193359375
is 0.005615234375
cipl 9.834766387939453e-05
inary 7.62939453125e-06
▁approach 0.1627197265625
▁involving 1.8427734375
▁health 1.986328125
care 0.05609130859375
▁profession 0.7958984375
als 1.3113021850585938e-06
, 1.400390625
▁nut 3.521484375
r 5.626678466796875e-05
ition 0.011932373046875
ists 0.0650634765625
, 0.020477294921875
▁and 0.06719970703125
▁behavior 2.537109375
al 0.02557373046875
▁ther 1.408203125
ap 0.004489898681640625
ists 0.0036468505859375
▁is 1.056640625
▁necessary 1.75390625
▁to 0.145263671875
▁ensure 1.595703125
▁personal 5.38671875
ized 0.0019292831420898438
, 2.099609375
▁hol 1.345703125
istic 6.091594696044922e-05
▁care 0.158935546875
▁for 0.77880859375
▁these 1.2255859375
▁patients 0.24853515625
, 4.74609375
▁taking 4.078125
▁into 0.05511474609375
▁account 0.3095703125
▁their 0.38818359375
▁specific 1.32421875
▁medical 2.4609375
▁history 1.3837890625
▁and 0.7568359375
▁risk 2.869140625
▁factors 0.1397705078125
. 0.07745361328125
